Catherine Soldano-Noble Executive Director, Marketing & Business Development Medpace, Inc. Cincinnati, OH 45212 Re: Amendment #2 to the Letter Agreement (“Amendment #2”) for certain initial services for the Amarin Trial A Study between Amarin Pharma...
Exhibit
4.89
Xxxxxxxxx
Xxxxxxx-Xxxxx
Executive
Director, Marketing & Business Development
Medpace,
Inc.
0000
Xxxxxx Xxxxxx
Xxxxxxxxxx,
XX 00000
Re: Amendment
#2 to the Letter Agreement (“Amendment #2”) for certain initial services for the
Amarin Trial A Study between Amarin Pharma Inc., Amarin Pharmaceuticals Ireland
Limited, and Medpace, Inc. (“Medpace”) dated 24 February 2009 as amended on 5
May 2009 (the “Initial Trial A Services Letter Agreement”).
Dear
Xxxxxxxxx:
The
parties acknowledge that Medpace has already provided certain of the Initial
Trial A Services, and the parties wish to amend Schedule A of the Initial Trial
A Services Letter Agreement to include certain additional activities to be
provided by Medpace prior to the parties entering into the MSA.
This
Amendment #2 is dated as of the date of last signature below.
Defined
terms in this letter shall have the same meanings as given to such terms in the
Initial Trial A Services Letter Agreement unless otherwise defined
herein.
In
consideration of the mutual covenants contained in the Initial Trial A Services
Letter Agreement IT IS NOW
HEREBY AGREED AS FOLLOWS:
|
1.
|
the
following activities (the “Additional Activities”)
will be deemed to be added to Schedule A of the Initial Trial Services
Letter Agreement:
|
|
Item
|
Amount
|
|
Purchase
of packaging components, project management,
|
$125,000
|
|
design
of labels
|
|
2.
|
the
Additional Activities shall be deemed to be Initial Trial A Services, as
such term is defined in the Initial Trial A Services Letter
Agreement;
|
|
3.
|
the
fees payable for the provision of the Additional Activities shall be
deemed to be included in the Total Initial Trial A Services Fees and
accordingly, the Total Trial A Service Fees shall remain unchanged;
and
|
|
4.
|
all
other provisions of the Initial Trial A Services Letter Agreement shall
remain unchanged and in full force and
effect.
|
Please
confirm your agreement with the above by signing this letter where indicated
below and returning a fully signed version to us.
Yours
sincerely,
Amarin
Pharma Inc.
by:___________________________________
Name:
Title:
Date:
Amarin
Pharmaceuticals Ireland Limited
by:___________________________________
Name:
Title:
Date:
AGREED
TO: Medpace Inc.
by:___________________________________
Name:
Title:
Date:
